TREAT: Darbepoetin alfa does not reduce outcomes of death, cardiovascular ... - HemOncToday PDF Print
HemOncTodayThe administration of darbepoetin alfa was not associated with a reduction in death, cardiovascular events or end-stage renal disease, according to results ...AHA: Stroke, VTE More Common with Darbepoetin MedPage TodayDarbepoetin Alfa Risky for Type 2 Diabetics With Kidney Disease: Presented at AHA DG NewsAmerican Heart Association Late-breaking Clinical Trial Report: Risks of

... read more

 
Share |
Copyright © 2025 Global Dialysis. All Rights Reserved.